Literature DB >> 15730863

Opposing roles for GABAA and GABAC receptors in short-term memory formation in young chicks.

M E Gibbs1, G A R Johnston.   

Abstract

The inhibitory neurotransmitter GABA has both inhibitory and enhancing effects on short-term memory for a bead discrimination task in the young chick. Low doses of GABA (1-3 pmol/hemisphere) injected into the multimodal association area of the chick forebrain, inhibit strongly reinforced memory, whereas higher doses (30-100 pmol/hemisphere) enhance weakly reinforced memory. The effect of both high and low doses of GABA is clearly on short-term memory in terms of both the time of injection and in the time that the memory loss occurs. We argue on the basis of relative sensitivities to GABA and to selective GABA receptor antagonists that low doses of GABA act at GABAC receptors (EC50 approximately 1 microM) and the higher doses of GABA act via GABAA receptors (EC50 approximately 10 microM). The selective GABAA receptor antagonist bicuculline inhibited strongly reinforced memory in a dose and time dependent manner, whereas the selective GABAC receptor antagonists TPMPA and P4MPA enhanced weakly reinforced in a dose and time dependent manner. Confirmation that different levels of GABA affect different receptor subtypes was demonstrated by the shift in the GABA dose-response curves to the selective antagonists. It is clear that GABA is involved in the control of short-term memory formation and its action, enhancing or inhibiting, depends on the level of GABA released at the time of learning.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730863     DOI: 10.1016/j.neuroscience.2004.11.033

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  GABA(A) ρ receptor mechanisms in the rat amygdala and its role in the modulation of fear and anxiety.

Authors:  Candy Flores-Gracia; Avril Nuche-Bricaire; Minerva Crespo-Ramírez; Ricardo Miledi; Kjell Fuxe; Miguel Pérez de la Mora
Journal:  Psychopharmacology (Berl)       Date:  2010-08-06       Impact factor: 4.530

Review 2.  GABA-ρ receptors: distinctive functions and molecular pharmacology.

Authors:  Moawiah M Naffaa; Sandy Hung; Mary Chebib; Graham A R Johnston; Jane R Hanrahan
Journal:  Br J Pharmacol       Date:  2017-04-12       Impact factor: 8.739

3.  Binding of muscimol-conjugated quantum dots to GABAC receptors.

Authors:  Hélène A Gussin; Ian D Tomlinson; Deborah M Little; Michael R Warnement; Haohua Qian; Sandra J Rosenthal; David R Pepperberg
Journal:  J Am Chem Soc       Date:  2006-12-13       Impact factor: 15.419

4.  The leukotriene B4 receptors BLT1 and BLT2 form an antagonistic sensitizing system in peripheral sensory neurons.

Authors:  Sebastian Zinn; Marco Sisignano; Katharina Kern; Sandra Pierre; Sorin Tunaru; Holger Jordan; Jing Suo; Elsa-Marie Treutlein; Carlo Angioni; Nerea Ferreiros; Andreas Leffler; Natasja DeBruin; Stefan Offermanns; Gerd Geisslinger; Klaus Scholich
Journal:  J Biol Chem       Date:  2017-02-27       Impact factor: 5.157

5.  Generation of recombinant guinea pig antibody fragments to the human GABAC receptor.

Authors:  Adnan Memic; Veronica V Volgina; Hélène A Gussin; David R Pepperberg; Brian K Kay
Journal:  J Immunol Methods       Date:  2011-02-26       Impact factor: 2.303

6.  Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology.

Authors:  Navnath Gavande; Izumi Yamamoto; Noeris K Salam; Tu-Hoa Ai; Peter M Burden; Graham A R Johnston; Jane R Hanrahan; Mary Chebib
Journal:  ACS Med Chem Lett       Date:  2010-10-19       Impact factor: 4.345

Review 7.  Neurochemicals for the investigation of GABA(C) receptors.

Authors:  Graham A R Johnston; Mary Chebib; Jane R Hanrahan; Kenneth N Mewett
Journal:  Neurochem Res       Date:  2010-10-21       Impact factor: 3.996

8.  Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory.

Authors:  Mary Chebib; Tina Hinton; Katrina L Schmid; Darren Brinkworth; Haohua Qian; Susana Matos; Hye-Lim Kim; Heba Abdel-Halim; Rohan J Kumar; Graham A R Johnston; Jane R Hanrahan
Journal:  J Pharmacol Exp Ther       Date:  2008-11-04       Impact factor: 4.030

9.  GABA(C) Receptors in the Lateral Amygdala: A Possible Novel Target for the Treatment of Fear and Anxiety Disorders?

Authors:  Catarina Cunha; Marie-H Monfils; Joseph E Ledoux
Journal:  Front Behav Neurosci       Date:  2010-03-12       Impact factor: 3.558

10.  Guanidino acids act as rho1 GABA(C) receptor antagonists.

Authors:  Mary Chebib; Navnath Gavande; Kit Yee Wong; Anna Park; Isabella Premoli; Kenneth N Mewett; Robin D Allan; Rujee K Duke; Graham A R Johnston; Jane R Hanrahan
Journal:  Neurochem Res       Date:  2009-04-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.